483 Chongqing Pharma Research Institute May 2016

483 Chongqing Pharma Research Institute May 2016

Peter Baker FDA, Marijo Kambere FDA$119.00 - Available Now

FDA investigators audited the Chongqing Pharma Research Institute - Zhongqing, China facility and issued inspectional observations (via FDA 483) on 19 May 2016.

Add To Cart

Product details

  • Category: Human Drugs
  • Inspection end: 19 May 2016
  • Location: Zhongqing, China